BRPI0811698A2 - Composição e método para aliviar um ou mais sintomas de um distúrbio neuropsiquiátrico em um indivíduo - Google Patents

Composição e método para aliviar um ou mais sintomas de um distúrbio neuropsiquiátrico em um indivíduo

Info

Publication number
BRPI0811698A2
BRPI0811698A2 BRPI0811698-9A2A BRPI0811698A BRPI0811698A2 BR PI0811698 A2 BRPI0811698 A2 BR PI0811698A2 BR PI0811698 A BRPI0811698 A BR PI0811698A BR PI0811698 A2 BRPI0811698 A2 BR PI0811698A2
Authority
BR
Brazil
Prior art keywords
relieve
symptoms
individual
composition
neuropsychiatric disorder
Prior art date
Application number
BRPI0811698-9A2A
Other languages
English (en)
Inventor
Huw M L Davies
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Publication of BRPI0811698A2 publication Critical patent/BRPI0811698A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
BRPI0811698-9A2A 2007-06-22 2008-06-23 Composição e método para aliviar um ou mais sintomas de um distúrbio neuropsiquiátrico em um indivíduo BRPI0811698A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94574607P 2007-06-22 2007-06-22
PCT/US2008/067884 WO2009002923A1 (en) 2007-06-22 2008-06-23 Substituted pyrrolidine compounds with central nervous system activity

Publications (1)

Publication Number Publication Date
BRPI0811698A2 true BRPI0811698A2 (pt) 2014-10-07

Family

ID=40186006

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0811698-9A2A BRPI0811698A2 (pt) 2007-06-22 2008-06-23 Composição e método para aliviar um ou mais sintomas de um distúrbio neuropsiquiátrico em um indivíduo

Country Status (6)

Country Link
US (1) US8329741B2 (pt)
EP (1) EP2170061A4 (pt)
JP (1) JP2010530900A (pt)
CN (1) CN101677546A (pt)
BR (1) BRPI0811698A2 (pt)
WO (1) WO2009002923A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2992645B1 (fr) * 2012-07-02 2014-08-01 Univ Claude Bernard Lyon Nouveaux derives de pyrrolidine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2081433A1 (pt) 1970-01-15 1971-12-03 Ciba Geigy Ag
US6410746B1 (en) * 1999-04-27 2002-06-25 Research Foundation Of State University Of New York, The Metal cataltsts and methods for making and using same
US20060241144A1 (en) * 2005-04-20 2006-10-26 Albert Cha Method for treating apathy syndrome

Also Published As

Publication number Publication date
EP2170061A4 (en) 2012-01-11
EP2170061A1 (en) 2010-04-07
US8329741B2 (en) 2012-12-11
US20090048329A1 (en) 2009-02-19
WO2009002923A1 (en) 2008-12-31
JP2010530900A (ja) 2010-09-16
CN101677546A (zh) 2010-03-24

Similar Documents

Publication Publication Date Title
BRPI0917330A2 (pt) aprefeiçoamento dinamico para apresentações de conteúdo
BRPI0908177A2 (pt) compósito elástico e método para produzir o mesmo
BRPI1009381A2 (pt) compostos, composição farmacêutica, método para tratar doença ou condição associada com função de trap1 em sujeito em necessidade do mesmo e uso de compostos e composição farmacêutica
BRPI0913298A2 (pt) materiais e processos para melhorar separações seletivas
BRPI0913892A2 (pt) métodos e sistemas de produção de combustível em pó em sistemas da fazenda à queima
BRPI0816777A2 (pt) método e sistema de distribuição de conteúdo para um ou mais dispositivos de usuários
BRPI0815407A2 (pt) Composições e métodos para controlar nematódeos
BR112012026848A2 (pt) suplemento alimentar ou medicinal e método para induzir saciedade em um indivíduo
DK2111126T3 (da) Forbedret stabilitet i vitamin- og mineraltilskud
DK2139452T3 (da) Topisk polyaphronsammensætning med D-vitamin og corticosteroid
BRPI0818963A2 (pt) Conjugado anticorpo-molécula parceira e método para tratar câncer em um indivíduo
BRPI0916630A2 (pt) composições para uso em construção e processo de aplicação das mesmas
BRPI0816817A2 (pt) PALMlLHA PARA UM PÉ DE UM INDIVÍDUO, E MÉTODO PARA PERMITIR A UM CONSUMIDOR EM UMA LOJA OBTER UMA PALMILHA
CL2012000487A1 (es) Composicion que comprende bifidobacterium longum baa-999 para tratar y/o prevenir trastornos gi funcionales.
BRPI0814079A2 (pt) Partículas amorfas sólidas e processo para obte-las para uso em medicamento inalável
BRPI0817182A2 (pt) Método para purificar um anticorpo e composições
BRPI0810806A2 (pt) Método para tratar uma lesão cutânea em um indivíduo
BRPI0819050A2 (pt) Método para desidroaromatizar metano
BRPI0820565A2 (pt) Métodos para aumentar o teor de amido em plantas
BRPI0818007A2 (pt) composição para regular o metabolismo lipídico
BRPI0815821A2 (pt) Composições e métodos que empregam antagonistas nmda para alcançar um efeito poupador de anestésico.
ES2396290T8 (es) Sistemas y métodos para combinar materiales
BRPI0922426A2 (pt) bio-óleo que possui reduzido teor de mineral e processo para a obtenção do mesmo
BRPI0906438A2 (pt) Isolamento de conteúdo por meio de processos em uma aplicação
BRPI0916744A2 (pt) filtro de fluxo direto e método para fazer o mesmo

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.